The mood and motivation stack
This is the stack we are most cautious about publishing, because the failure mode is someone delaying real treatment. Depression is a serious, treatable medical condition, and no compound listed here has been tested against it.
The bottleneck
Overlapping: blunted reward signalling, suppressed plasticity, and in a subset of people, elevated inflammation.
What is in it, and why
- SelankEvidence grade: Early human data
Anxiolysis without sedation in Russian comparative trials, plus effects on IL-6.
Timing: Split through the day; some report using it opposite a stimulating compound.
- SemaxEvidence grade: Early human data
The plasticity and attention side, and modulation of dopaminergic tone in animal models.
Timing: Morning only. Late dosing costs sleep.
- NAD+ precursorsEvidence grade: Human trials
Substrate for the energy-expensive business of neurotransmitter synthesis.
Timing: Morning with food.
Why these go together
- Selank and Semax come from the same Russian research programme and are frequently studied as a pair, pulling in opposite directions — calming and activating.
- Both touch the plasticity pathway, which is where modern depression research has concentrated.
Conflicts and risks
Consider this
Consider this
Consider this
The practice protocol
This half is not optional. It shares the mechanism, and it usually has the better evidence.
- 1.Daily gratitude practice — it acts on the reward system by shifting attention to rewards already present rather than ones requiring pursuit.
- 2.Craving-surfing when an urge to escape appears: observe it without acting, and let it subside. This is the trainable skill underneath recovery.
- 3.Morning mental rehearsal of the person you are trying to become, before the day's inputs set your state.
- 4.Reduce high-peak, low-effort stimulus exposure so that ordinary rewards start registering again.
Nutrition and sleep foundations
These gate everything above them. A stack running on five hours of sleep and insufficient protein is mostly an expensive placebo.
- Morning daylight within an hour of waking — the strongest available lever on circadian and mood rhythm.
- Protein for tyrosine and tryptophan, the precursors for dopamine and serotonin.
- Alcohol reduction. It is a depressant that also depletes NAD+ and fragments sleep.
- Fixed wake time. Sleep-deprived brains show reduced D2 receptor availability in human imaging.
The evidence ceiling
There is no evidence base for treating depression with any of these compounds. What exists is a mechanistic rationale plus small anxiolytic trials from a single research tradition. Therapy and, where indicated, medication have vastly more evidence than anything on this page.
Common questions
- No. Antidepressants and psychotherapy have decades of trial evidence; these compounds have none for this indication. If you are struggling, that conversation belongs with a doctor. Nothing on this site is a treatment.
- Please stop reading protocols and reach out for help now. Our crisis resources page lists free confidential lines that answer immediately, and emergency services are always an appropriate call.